 | • レポートコード：QY2203B02153 • 出版社/出版日：QYResearch / 2022年3月18日 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のオンコロジー前臨床CROの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にオンコロジー前臨床CROの世界市場のxxx％を占める「血液がん」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「In Vitro」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のオンコロジー前臨床CROの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのオンコロジー前臨床CRO市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのオンコロジー前臨床CRO市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 オンコロジー前臨床CROのグローバル主要メーカーには、Crown Bioscience、Charles River、ICON、Eurofins Scientific、Taconic Biosciences、Covance、EVOTEC、The Jackson Laboratory、MI Bioresearch、Champion Oncology、Wuxi AppTec.、Xentech、Living Tumor Laboratoryなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 オンコロジー前臨床CRO市場は、種類と用途によって区分されます。世界のオンコロジー前臨床CRO市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 血液がん、固形腫瘍、その他 【用途別セグメント】 In Vitro、In Vivo 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - オンコロジー前臨床CRO製品概要 - 種類別市場（血液がん、固形腫瘍、その他） - 用途別市場（In Vitro、In Vivo） - 調査の目的 ・エグゼクティブサマリー - 世界のオンコロジー前臨床CRO販売量予測2017-2028 - 世界のオンコロジー前臨床CRO売上予測2017-2028 - オンコロジー前臨床CROの地域別販売量 - オンコロジー前臨床CROの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別オンコロジー前臨床CRO販売量 - 主要メーカー別オンコロジー前臨床CRO売上 - 主要メーカー別オンコロジー前臨床CRO価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（血液がん、固形腫瘍、その他） - オンコロジー前臨床CROの種類別販売量 - オンコロジー前臨床CROの種類別売上 - オンコロジー前臨床CROの種類別価格 ・用途別市場規模（In Vitro、In Vivo） - オンコロジー前臨床CROの用途別販売量 - オンコロジー前臨床CROの用途別売上 - オンコロジー前臨床CROの用途別価格 ・北米市場 - 北米のオンコロジー前臨床CRO市場規模（種類別、用途別） - 主要国別のオンコロジー前臨床CRO市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのオンコロジー前臨床CRO市場規模（種類別、用途別） - 主要国別のオンコロジー前臨床CRO市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のオンコロジー前臨床CRO市場規模（種類別、用途別） - 主要国別のオンコロジー前臨床CRO市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のオンコロジー前臨床CRO市場規模（種類別、用途別） - 主要国別のオンコロジー前臨床CRO市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのオンコロジー前臨床CRO市場規模（種類別、用途別） - 主要国別のオンコロジー前臨床CRO市場規模（トルコ、サウジアラビア） ・企業情報 Crown Bioscience、Charles River、ICON、Eurofins Scientific、Taconic Biosciences、Covance、EVOTEC、The Jackson Laboratory、MI Bioresearch、Champion Oncology、Wuxi AppTec.、Xentech、Living Tumor Laboratory ・産業チェーン及び販売チャネル分析 - オンコロジー前臨床CROの産業チェーン分析 - オンコロジー前臨床CROの原材料 - オンコロジー前臨床CROの生産プロセス - オンコロジー前臨床CROの販売及びマーケティング - オンコロジー前臨床CROの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - オンコロジー前臨床CROの産業動向 - オンコロジー前臨床CROのマーケットドライバー - オンコロジー前臨床CROの課題 - オンコロジー前臨床CROの阻害要因 ・主な調査結果 |
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
Market Analysis and Insights: Global Oncology Based Preclinical CRO Market
The global Oncology Based Preclinical CRO market size is projected to reach US$ 870.1 million by 2028, from US$ 380.3 million in 2021, at a CAGR of 12.4% during 2022-2028.
The industry’s leading producers are Crown Bioscience, Charles River and ICON, with revenues of 18.32 percent, 13.86 percent and 9.13 percent in 2019.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Based Preclinical CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Based Preclinical CRO market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Based Preclinical CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Based Preclinical CRO market.
Global Oncology Based Preclinical CRO Scope and Market Size
Oncology Based Preclinical CRO market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Oncology Based Preclinical CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Blood Cancer
Solid Tumors
Others
Segment by Application
In Vitro
In Vivo
By Company
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncology Based Preclinical CRO Market Perspective (2017-2028)
2.2 Oncology Based Preclinical CRO Growth Trends by Region
2.2.1 Oncology Based Preclinical CRO Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oncology Based Preclinical CRO Historic Market Size by Region (2017-2022)
2.2.3 Oncology Based Preclinical CRO Forecasted Market Size by Region (2023-2028)
2.3 Oncology Based Preclinical CRO Market Dynamics
2.3.1 Oncology Based Preclinical CRO Industry Trends
2.3.2 Oncology Based Preclinical CRO Market Drivers
2.3.3 Oncology Based Preclinical CRO Market Challenges
2.3.4 Oncology Based Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology Based Preclinical CRO Players by Revenue
3.1.1 Global Top Oncology Based Preclinical CRO Players by Revenue (2017-2022)
3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Players (2017-2022)
3.2 Global Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Based Preclinical CRO Revenue
3.4 Global Oncology Based Preclinical CRO Market Concentration Ratio
3.4.1 Global Oncology Based Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Based Preclinical CRO Revenue in 2021
3.5 Oncology Based Preclinical CRO Key Players Head office and Area Served
3.6 Key Players Oncology Based Preclinical CRO Product Solution and Service
3.7 Date of Enter into Oncology Based Preclinical CRO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Based Preclinical CRO Breakdown Data by Type
4.1 Global Oncology Based Preclinical CRO Historic Market Size by Type (2017-2022)
4.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2023-2028)
5 Oncology Based Preclinical CRO Breakdown Data by Application
5.1 Global Oncology Based Preclinical CRO Historic Market Size by Application (2017-2022)
5.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oncology Based Preclinical CRO Market Size (2017-2028)
6.2 North America Oncology Based Preclinical CRO Market Size by Type
6.2.1 North America Oncology Based Preclinical CRO Market Size by Type (2017-2022)
6.2.2 North America Oncology Based Preclinical CRO Market Size by Type (2023-2028)
6.2.3 North America Oncology Based Preclinical CRO Market Share by Type (2017-2028)
6.3 North America Oncology Based Preclinical CRO Market Size by Application
6.3.1 North America Oncology Based Preclinical CRO Market Size by Application (2017-2022)
6.3.2 North America Oncology Based Preclinical CRO Market Size by Application (2023-2028)
6.3.3 North America Oncology Based Preclinical CRO Market Share by Application (2017-2028)
6.4 North America Oncology Based Preclinical CRO Market Size by Country
6.4.1 North America Oncology Based Preclinical CRO Market Size by Country (2017-2022)
6.4.2 North America Oncology Based Preclinical CRO Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Oncology Based Preclinical CRO Market Size (2017-2028)
7.2 Europe Oncology Based Preclinical CRO Market Size by Type
7.2.1 Europe Oncology Based Preclinical CRO Market Size by Type (2017-2022)
7.2.2 Europe Oncology Based Preclinical CRO Market Size by Type (2023-2028)
7.2.3 Europe Oncology Based Preclinical CRO Market Share by Type (2017-2028)
7.3 Europe Oncology Based Preclinical CRO Market Size by Application
7.3.1 Europe Oncology Based Preclinical CRO Market Size by Application (2017-2022)
7.3.2 Europe Oncology Based Preclinical CRO Market Size by Application (2023-2028)
7.3.3 Europe Oncology Based Preclinical CRO Market Share by Application (2017-2028)
7.4 Europe Oncology Based Preclinical CRO Market Size by Country
7.4.1 Europe Oncology Based Preclinical CRO Market Size by Country (2017-2022)
7.4.2 Europe Oncology Based Preclinical CRO Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncology Based Preclinical CRO Market Size (2017-2028)
8.2 Asia-Pacific Oncology Based Preclinical CRO Market Size by Type
8.2.1 Asia-Pacific Oncology Based Preclinical CRO Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oncology Based Preclinical CRO Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oncology Based Preclinical CRO Market Share by Type (2017-2028)
8.3 Asia-Pacific Oncology Based Preclinical CRO Market Size by Application
8.3.1 Asia-Pacific Oncology Based Preclinical CRO Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oncology Based Preclinical CRO Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oncology Based Preclinical CRO Market Share by Application (2017-2028)
8.4 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region
8.4.1 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncology Based Preclinical CRO Market Size (2017-2028)
9.2 Latin America Oncology Based Preclinical CRO Market Size by Type
9.2.1 Latin America Oncology Based Preclinical CRO Market Size by Type (2017-2022)
9.2.2 Latin America Oncology Based Preclinical CRO Market Size by Type (2023-2028)
9.2.3 Latin America Oncology Based Preclinical CRO Market Share by Type (2017-2028)
9.3 Latin America Oncology Based Preclinical CRO Market Size by Application
9.3.1 Latin America Oncology Based Preclinical CRO Market Size by Application (2017-2022)
9.3.2 Latin America Oncology Based Preclinical CRO Market Size by Application (2023-2028)
9.3.3 Latin America Oncology Based Preclinical CRO Market Share by Application (2017-2028)
9.4 Latin America Oncology Based Preclinical CRO Market Size by Country
9.4.1 Latin America Oncology Based Preclinical CRO Market Size by Country (2017-2022)
9.4.2 Latin America Oncology Based Preclinical CRO Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology Based Preclinical CRO Market Size (2017-2028)
10.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Type
10.2.1 Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oncology Based Preclinical CRO Market Share by Type (2017-2028)
10.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Application
10.3.1 Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oncology Based Preclinical CRO Market Share by Application (2017-2028)
10.4 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country
10.4.1 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Oncology Based Preclinical CRO Introduction
11.1.4 Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.1.5 Crown Bioscience Recent Developments
11.2 Charles River
11.2.1 Charles River Company Details
11.2.2 Charles River Business Overview
11.2.3 Charles River Oncology Based Preclinical CRO Introduction
11.2.4 Charles River Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.2.5 Charles River Recent Developments
11.3 ICON
11.3.1 ICON Company Details
11.3.2 ICON Business Overview
11.3.3 ICON Oncology Based Preclinical CRO Introduction
11.3.4 ICON Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.3.5 ICON Recent Developments
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Oncology Based Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.4.5 Eurofins Scientific Recent Developments
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Details
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Oncology Based Preclinical CRO Introduction
11.5.4 Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.5.5 Taconic Biosciences Recent Developments
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance Oncology Based Preclinical CRO Introduction
11.6.4 Covance Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.6.5 Covance Recent Developments
11.7 EVOTEC
11.7.1 EVOTEC Company Details
11.7.2 EVOTEC Business Overview
11.7.3 EVOTEC Oncology Based Preclinical CRO Introduction
11.7.4 EVOTEC Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.7.5 EVOTEC Recent Developments
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Details
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.8.5 The Jackson Laboratory Recent Developments
11.9 MI Bioresearch
11.9.1 MI Bioresearch Company Details
11.9.2 MI Bioresearch Business Overview
11.9.3 MI Bioresearch Oncology Based Preclinical CRO Introduction
11.9.4 MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.9.5 MI Bioresearch Recent Developments
11.10 Champion Oncology
11.10.1 Champion Oncology Company Details
11.10.2 Champion Oncology Business Overview
11.10.3 Champion Oncology Oncology Based Preclinical CRO Introduction
11.10.4 Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.10.5 Champion Oncology Recent Developments
11.11 Wuxi AppTec.
11.11.1 Wuxi AppTec. Company Details
11.11.2 Wuxi AppTec. Business Overview
11.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Introduction
11.11.4 Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.11.5 Wuxi AppTec. Recent Developments
11.12 Xentech
11.12.1 Xentech Company Details
11.12.2 Xentech Business Overview
11.12.3 Xentech Oncology Based Preclinical CRO Introduction
11.12.4 Xentech Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.12.5 Xentech Recent Developments
11.13 Living Tumor Laboratory
11.13.1 Living Tumor Laboratory Company Details
11.13.2 Living Tumor Laboratory Business Overview
11.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Introduction
11.13.4 Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2017-2022)
11.13.5 Living Tumor Laboratory Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Oncology Based Preclinical CRO Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Blood Cancer
Table 3. Key Players of Solid Tumors
Table 4. Key Players of Others
Table 5. Global Oncology Based Preclinical CRO Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Oncology Based Preclinical CRO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Oncology Based Preclinical CRO Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Oncology Based Preclinical CRO Market Share by Region (2017-2022)
Table 9. Global Oncology Based Preclinical CRO Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Oncology Based Preclinical CRO Market Share by Region (2023-2028)
Table 11. Oncology Based Preclinical CRO Market Trends
Table 12. Oncology Based Preclinical CRO Market Drivers
Table 13. Oncology Based Preclinical CRO Market Challenges
Table 14. Oncology Based Preclinical CRO Market Restraints
Table 15. Global Oncology Based Preclinical CRO Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Oncology Based Preclinical CRO Revenue Share by Players (2017-2022)
Table 17. Global Top Oncology Based Preclinical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2021)
Table 18. Ranking of Global Top Oncology Based Preclinical CRO Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Oncology Based Preclinical CRO Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oncology Based Preclinical CRO Product Solution and Service
Table 22. Date of Enter into Oncology Based Preclinical CRO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2017-2022)
Table 26. Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2023-2028)
Table 28. Global Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Oncology Based Preclinical CRO Revenue Share by Application (2017-2022)
Table 30. Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Oncology Based Preclinical CRO Revenue Share by Application (2023-2028)
Table 32. North America Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Oncology Based Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Oncology Based Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Oncology Based Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Oncology Based Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Oncology Based Preclinical CRO Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Oncology Based Preclinical CRO Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Oncology Based Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Oncology Based Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Oncology Based Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Oncology Based Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
Table 62. Crown Bioscience Company Details
Table 63. Crown Bioscience Business Overview
Table 64. Crown Bioscience Oncology Based Preclinical CRO Product
Table 65. Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 66. Crown Bioscience Recent Developments
Table 67. Charles River Company Details
Table 68. Charles River Business Overview
Table 69. Charles River Oncology Based Preclinical CRO Product
Table 70. Charles River Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 71. Charles River Recent Developments
Table 72. ICON Company Details
Table 73. ICON Business Overview
Table 74. ICON Oncology Based Preclinical CRO Product
Table 75. ICON Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 76. ICON Recent Developments
Table 77. Eurofins Scientific Company Details
Table 78. Eurofins Scientific Business Overview
Table 79. Eurofins Scientific Oncology Based Preclinical CRO Product
Table 80. Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 81. Eurofins Scientific Recent Developments
Table 82. Taconic Biosciences Company Details
Table 83. Taconic Biosciences Business Overview
Table 84. Taconic Biosciences Oncology Based Preclinical CRO Product
Table 85. Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 86. Taconic Biosciences Recent Developments
Table 87. Covance Company Details
Table 88. Covance Business Overview
Table 89. Covance Oncology Based Preclinical CRO Product
Table 90. Covance Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 91. Covance Recent Developments
Table 92. EVOTEC Company Details
Table 93. EVOTEC Business Overview
Table 94. EVOTEC Oncology Based Preclinical CRO Product
Table 95. EVOTEC Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 96. EVOTEC Recent Developments
Table 97. The Jackson Laboratory Company Details
Table 98. The Jackson Laboratory Business Overview
Table 99. The Jackson Laboratory Oncology Based Preclinical CRO Product
Table 100. The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 101. The Jackson Laboratory Recent Developments
Table 102. MI Bioresearch Company Details
Table 103. MI Bioresearch Business Overview
Table 104. MI Bioresearch Oncology Based Preclinical CRO Product
Table 105. MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 106. MI Bioresearch Recent Developments
Table 107. Champion Oncology Company Details
Table 108. Champion Oncology Business Overview
Table 109. Champion Oncology Oncology Based Preclinical CRO Product
Table 110. Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 111. Champion Oncology Recent Developments
Table 112. Wuxi AppTec. Company Details
Table 113. Wuxi AppTec. Business Overview
Table 114. Wuxi AppTec. Oncology Based Preclinical CRO Product
Table 115. Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 116. Wuxi AppTec. Recent Developments
Table 117. Xentech Company Details
Table 118. Xentech Business Overview
Table 119. Xentech Oncology Based Preclinical CRO Product
Table 120. Xentech Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 121. Xentech Recent Developments
Table 122. Living Tumor Laboratory Company Details
Table 123. Living Tumor Laboratory Business Overview
Table 124. Living Tumor Laboratory Oncology Based Preclinical CRO Product
Table 125. Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
Table 126. Living Tumor Laboratory Recent Developments
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncology Based Preclinical CRO Market Share by Type: 2021 VS 2028
Figure 2. Blood Cancer Features
Figure 3. Solid Tumors Features
Figure 4. Others Features
Figure 5. Global Oncology Based Preclinical CRO Market Share by Application: 2021 VS 2028
Figure 6. In Vitro Case Studies
Figure 7. In Vivo Case Studies
Figure 8. Oncology Based Preclinical CRO Report Years Considered
Figure 9. Global Oncology Based Preclinical CRO Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Oncology Based Preclinical CRO Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Oncology Based Preclinical CRO Market Share by Region: 2021 VS 2028
Figure 12. Global Oncology Based Preclinical CRO Market Share by Players in 2021
Figure 13. Global Top Oncology Based Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Oncology Based Preclinical CRO Revenue in 2021
Figure 15. North America Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
Figure 17. North America Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
Figure 18. North America Oncology Based Preclinical CRO Market Size Share by Country (2017-2028)
Figure 19. United States Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
Figure 23. Europe Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
Figure 24. Europe Oncology Based Preclinical CRO Market Size Share by Country (2017-2028)
Figure 25. Germany Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Oncology Based Preclinical CRO Market Size Share by Region (2017-2028)
Figure 35. China Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Oncology Based Preclinical CRO Market Size Share by Country (2017-2028)
Figure 45. Mexico Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Oncology Based Preclinical CRO Market Size Share by Country (2017-2028)
Figure 51. Turkey Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Crown Bioscience Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 55. Charles River Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 56. ICON Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 57. Eurofins Scientific Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 58. Taconic Biosciences Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 59. Covance Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 60. EVOTEC Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 61. The Jackson Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 62. MI Bioresearch Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 63. Champion Oncology Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 64. Wuxi AppTec. Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 65. Xentech Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 66. Living Tumor Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed